title: [In vitro synergic lymphocyte stimulation in HIV-1 infected patients using inosine derivatives and radio-detoxified endotoxin].
abstract: Restoration of immune functions through promoting cell cycle might delay acquired immunodeficiency syndrome development. Therefore, stimulation of peripheral lymphocytes of human immunodeficiency virus-1 infected patients in successive clinical stages was studied by phytohaemagglutinin and other stimulants. In vitro blastogenesis was quantitated by 3H-thymidine uptake. Stimulation by phytohaemagglutinin decreased in patients with AIDS related complex to 63.1%, with AIDS to 13.6% of control values. Small amount of recombinant interleukin-2 or indomethacin solely not promoting lymphocytes, increased response to phytohaemagglutinin minimally. Alone ineffective methyl-ester and methyl-phosphonate inosine derivatives augmented phytohaemagglutinin-response of controls and patients with AIDS related complex by approx. 1.5-fold, but the effect in the case of AIDS patients was minimal. Radio-detoxified endotoxin alone or in combination with phytohaemagglutinin stimulated lymphocytes of both controls and patients with AIDS related complex slightly. Lymphocyte stimulation of patients with AIDS related complex was augmented in concentration-dependent manner, and by synergic effect it approached phytohaemagglutinin-stimulated blastogenesis of controls. Anergy due to human immunodeficiency virus-1 infection damages synchronisation of secondary messenger systems induced on cell surface receptors, therefore their selective influence by recombinant interleukin-2 or indomethacin is less efficient. Inosine derivatives promote cell cycle by inhibiting cyclic adenosine 3',5'-monophosphate production. In the early stage of virus infection, radio-detoxified endotoxin might bind to receptors of immature T cells and facilitate cell cycle through cyclic guanosine 3',5'-monophosphate stimulation. The clinical trials of radio-detoxified endotoxin (Tolerin) have already been launched.
authors.affiliation: Mikrobiológiai Intézet, Semmelweis Orvostudományi Egyetem, Budapest.
authors.forename: J
authors.initials: J
authors.lastname: Ongrádi
authors.forename: J W
authors.initials: JW
authors.lastname: Hadden
authors.forename: L
authors.initials: L
authors.lastname: Bertók
authors.forename: S
authors.initials: S
authors.lastname: Specter
authors.forename: R
authors.initials: R
authors.lastname: Nelson
authors.forename: H
authors.initials: H
authors.lastname: Friedman
mesh_terms: D000386:AIDS-Related Complex / Q000628:therapy*; D000163:Acquired Immunodeficiency Syndrome / Q000628:therapy*; D000328:Adult; D004731:Endotoxins / Q000528:radiation effects / Q000627:therapeutic use*; D015658:HIV Infections / Q000628:therapy*; D015497:HIV-1; D006801:Humans; D007114:Immunization; D007288:Inosine / Q000008:administration & dosage; D007376:Interleukin-2 / Q000008:administration & dosage; D008214:Lymphocytes / Q000187:drug effects*; D008297:Male; D010835:Phytohemagglutinins / Q000008:administration & dosage; D013936:Thymidine / Q000008:administration & dosage
chemical_list: D004731:Endotoxins; D007376:Interleukin-2; D010835:Phytohemagglutinins; C010797:tolerin; D007288:Inosine; D013936:Thymidine